GE HealthCare Technologies (NASDAQ:GEHC – Get Free Report) had its price objective raised by Morgan Stanley from $74.00 to $86.00 in a report issued on Monday, Benzinga reports. The brokerage currently has an “equal weight” rating on the stock. Morgan Stanley’s price target points to a potential upside of 3.40% from the stock’s current price.
Other analysts have also issued reports about the stock. Mizuho boosted their price objective on shares of GE HealthCare Technologies from $94.00 to $96.00 and gave the company a “buy” rating in a report on Wednesday, February 7th. UBS Group raised shares of GE HealthCare Technologies from a “sell” rating to a “neutral” rating and increased their price objective for the stock from $66.00 to $88.00 in a research report on Monday. Finally, Jefferies Financial Group initiated coverage on GE HealthCare Technologies in a research report on Thursday, November 30th. They issued a “hold” rating and a $80.00 target price on the stock. Five investment analysts have rated the stock with a hold rating and seven have given a buy rating to the company. According to data from MarketBeat, GE HealthCare Technologies has a consensus rating of “Moderate Buy” and an average target price of $87.82.
GE HealthCare Technologies Stock Up 2.2 %
GE HealthCare Technologies (NASDAQ:GEHC – Get Free Report) last posted its earnings results on Tuesday, February 6th. The company reported $1.18 EPS for the quarter, beating analysts’ consensus estimates of $1.07 by $0.11. The firm had revenue of $5.20 billion for the quarter, compared to analysts’ expectations of $5.09 billion. GE HealthCare Technologies had a return on equity of 25.58% and a net margin of 8.02%. The company’s quarterly revenue was up 5.3% on a year-over-year basis. During the same period last year, the firm earned $1.31 EPS. On average, sell-side analysts expect that GE HealthCare Technologies will post 4.3 EPS for the current year.
Hedge Funds Weigh In On GE HealthCare Technologies
A number of institutional investors have recently made changes to their positions in the stock. Meitav Investment House Ltd. acquired a new position in shares of GE HealthCare Technologies in the second quarter worth about $113,000. Pin Oak Investment Advisors Inc. acquired a new stake in GE HealthCare Technologies during the second quarter valued at approximately $25,000. Center for Financial Planning Inc. acquired a new position in shares of GE HealthCare Technologies in the 2nd quarter worth approximately $26,000. Larson Financial Group LLC bought a new stake in shares of GE HealthCare Technologies in the 2nd quarter valued at approximately $27,000. Finally, Resources Management Corp CT ADV acquired a new stake in shares of GE HealthCare Technologies during the 2nd quarter valued at approximately $28,000. 79.18% of the stock is owned by institutional investors and hedge funds.
GE HealthCare Technologies Company Profile
GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, Europe, the Middle East, Africa, China, Taiwan, Mongolia, Hong Kong, and internationally.
- Five stocks we like better than GE HealthCare Technologies
- What is the Dogs of the Dow Strategy? Overview and Examples
- 3 attractive stocks that insiders are buying
- What Does a Gap Up Mean in Stocks? How to Play the Gap
- Alpha and Omega Semiconductor ready to bounce, DOJ cloud lifts
- What Investors Must Know About Over-the-Counter (OTC) Stocks
- Wendy’s vs Shake Shack: Out with the new, in with the old?
Receive News & Ratings for GE HealthCare Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GE HealthCare Technologies and related companies with MarketBeat.com's FREE daily email newsletter.